Navigation Links
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Date:9/2/2008

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the appointment of Patrick O'Connor, PhD, Vice President, Research, Michael J. LaBarre, PhD, Vice President, Product Development, and James E. Cartoni, Vice President, Legal.

"Halozyme is committed to attracting, developing, and retaining world- class talent. We are delighted that seasoned executives such as Patrick, Michael, and Jim have joined the team. Successfully recruiting executives of this caliber underscores our commitment to finding exceptional talent, and also reflects the high level of excitement Halozyme is generating in the biotech industry," said Jonathan Lim, MD, President and CEO of Halozyme Therapeutics. "Their broad collective experience in drug development, formulation, analytical methodology, manufacturing, and the legal aspects of biotechnology brings further breadth and depth to our leadership team. All three executives will work closely with our senior management to enable Halozyme to achieve its business objectives."

Patrick O'Connor's responsibilities will include leadership of Halozyme's multiple biology and chemistry research programs. Dr. O'Connor joins Halozyme from Ardea Biosciences where he was Senior Vice President and Chief Scientific Officer. Prior to joining Ardea, Dr. O'Connor served in various executive research positions at Pfizer Global Research & Development and Agouron Pharmaceuticals (now Pfizer, Inc.) from 1998 to 2007. His last position with Pfizer as Vice President, Research Therapeutic Area Head, Global Oncology, included responsibility for setting the overall global oncolo
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
3. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
5. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
6. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
7. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
8. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
9. Halozyme Therapeutics Amends Stockholder Rights Plan
10. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
11. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Drug Discovery Technologies - A G... ,, http://www.reportlinker.com/p0164246/Drug-...-Trends--Opportunities.html ,, Drug discovery ...y pharmaceutical company,s business strategy. Ther...
(Date:12/2/2009)...2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.... ONCY ) announced today that in connection with it...ters have exercised in full their over-allotment o...ach unit is comprised of one common share and 0.4 ...t a price of US$3.00 per unit. Each whole common s...
(Date:12/2/2009)... Israel, December 2 Gamida Cell an...reclinical (animal study) safety and,efficacy of a...om Weill,Cornell Medical College and Gamida Cell. ...anemias such as Cooley,s Anemia. , Gamida...pand, ex vivo,populations of stem/progenitor cell...
(Date:12/2/2009)...PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NAS...iopharmaceutical company focused on endocrine ther...od and Drug Administration (FDA) has granted Fast ...ay inhibitor compound, perifosine (KRX-0401), for ...oma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( KE...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... Christoph Sachse, , Andrew W... David Brown Ambion, Inc. , ... a powerful , tool for understa... wherein short double-stranded RNA...As (siRNAs) direct the degradation of transcripts ...
...s use and recommend , a number of differe...oincide , with the suggested controls det... Cell Biology [1]. Here we outline these vario...of each in RNAi experiments. , , ..., href="http://www.ambion....
...ior Scientist, , Ambion, Inc.) ...nterference (RNAi) , can be use..., studies occurred with the semin...ation describing the use of small interfering RNAs...in 2001. In less than two years, , ...
Other Biology Technology:siRNA Design: It's All in the Algorithm 2siRNA Design: It's All in the Algorithm 3siRNA Design: It's All in the Algorithm 4siRNA Design: It's All in the Algorithm 5siRNA Design: It's All in the Algorithm 6siRNA Design: It's All in the Algorithm 7siRNA Design: It's All in the Algorithm 8siRNA Design: It's All in the Algorithm 9siRNA Design: It's All in the Algorithm 10RNAi: The Controls You Need 2RNAi: The Controls You Need 3RNAi: The Controls You Need 4RNAi: The Controls You Need 5RNAi: The Controls You Need 6RNAi: The Controls You Need 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 2RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 3RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 4RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 5RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 6RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 7RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs 8
(Date:12/4/2009)...l Botanic Gardens, Kew and the Natural History Mus...s far more widespread than previously thought, wit... least part way to being "meat eaters". A review p...nd modern insights into vegetable carnivory, is pu...Journal of the Linnean Society . , Carnivorous p...
(Date:12/4/2009)... model of heart cells, University of Iowa investig...me, calmodulin kinase II (CaM kinase), disrupts th...udy, which also involved Columbia University, was ...tational Biology . , "Recently, researchers hav... as a critical regulator of the heart,s response t...
(Date:12/3/2009)... Hausen and his co-workers discovered that specifi...al cancer. Scientists soon found out how these pat...y that the main culprits are viral proteins E6 and...ontrol functions, thus promoting cell growth. , ...Z have now discovered another mechanism by which t...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2Statement by Don Spence CEO Philips Home Healthcare Solutions Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 6050 1Statement by Don Spence CEO Philips Home Healthcare Solutions Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 6050 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 1Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year to Date 2009 Financial Results 6048 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 1Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad Spectrum Therapeutic for 6046 3
...ors roamed 60,000 years ago? ,Now you can find out...oject tracing the genetic and migratory history of...rom all over the world can supply their DNA to the...sity of Arizona in Tucson will do the genetic anal...undertaking to unravel the origins and migratory h...
...t the University of Pennsylvania School of Medicin...cer that closely mimics disease progression in hum...s for this deadly disease. Advanced pancreatic can...e-year survival rate after chemotherapy of only 17...nal Cancer Institute. , Sunil R. Hingorani, MD, Ph...
...geria Syndrome (HGPS) -- a disease associated with...ording to findings by scientists at the National C...utes of Health (NIH). Using specially modified seg... and Tom Misteli, PhD, reversed the abnormalities ...d with the key protein, lamin A. By demonstrating ...
Other Biology News:The biggest family tree ever 2The biggest family tree ever 3Disease progression model of pancreatic cancer developed by Penn researchers 2Disease progression model of pancreatic cancer developed by Penn researchers 3Cellular Defects in Premature Aging Disease are Reversible 2Cellular Defects in Premature Aging Disease are Reversible 3
...ovides excellent performance, reliability and flex..., including washing of ELISAs, cellular assays and...uch as for PCR clean-up. The platforms outstanding...ate washers, with options including a process cont...
...ts Laser Capture Microdissection (LCM) enables yo...uracy of molecular assays by starting with samples...ctures isolated from whole tissue or cytology samp...oped in 1996 at the National Institutes of Health ...
BioWorks 3.3 from Thermo Scientific
...screen, without Camera • The digimage sys...ion. It is computer free for compact space require... TFT color liquid crystal display is it's specific...rescent gels, colorimetric gels, auto radiography ...
Biology Products: